Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


18.02.2019

2 Am J Gastroenterol
2 BMC Gastroenterol
1 Clin Exp Immunol
1 Clin Gastroenterol Hepatol
2 Dig Dis Sci
1 Dis Colon Rectum
1 Gut
5 Inflamm Bowel Dis
3 J Crohns Colitis
1 J Immunol
1 Lancet Gastroenterol Hepatol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. SIEGEL CA
    Placing Value on Telemedicine for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jan 30. doi: 10.14309/ajg.0000000000000151.
    PubMed     Text format     Abstract available

  2. HATA K, Anzai H, Ikeuchi H, Futami K, et al
    Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
    Am J Gastroenterol. 2019 Feb 8. doi: 10.14309/ajg.0000000000000117.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  3. NOISEUX I, Veilleux S, Bitton A, Kohen R, et al
    Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures.
    BMC Gastroenterol. 2019;19:30.
    PubMed     Text format     Abstract available

  4. CRONIN O, Barton W, Moran C, Sheehan D, et al
    Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial.
    BMC Gastroenterol. 2019;19:29.
    PubMed     Text format     Abstract available


    Clin Exp Immunol

  5. MOULTON CD, Pavlidis P, Norton C, Norton S, et al
    Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
    Clin Exp Immunol. 2019 Feb 14. doi: 10.1111/cei.13276.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  6. BURISCH J, Jess T
    Does eradication of Helicobacter pylori cause inflammatory bowel disease?
    Clin Gastroenterol Hepatol. 2019 Feb 12. pii: S1542-3565(19)30153.
    PubMed     Text format    


    Dig Dis Sci

  7. XU F, Dahlhamer JM, Terlizzi EP, Wheaton AG, et al
    Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05494.
    PubMed     Text format     Abstract available

  8. LIU JJ, Rosson TB, Xie JJ, Harris ZP, et al
    Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05485.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  9. SCEATS LA, Morris AM, Bundorf MK, Park KT, et al
    Sex Differences in Treatment Strategies Among Patients With Ulcerative Colitis: A Retrospective Cohort Analysis of Privately Insured Patients.
    Dis Colon Rectum. 2019 Feb 8. doi: 10.1097/DCR.0000000000001342.
    PubMed     Text format     Abstract available


    Gut

  10. BLACKWELL J, Saxena S, Pollok RC
    Changing trends in coding for depression among the UK inflammatory bowel disease population.
    Gut. 2019 Feb 13. pii: gutjnl-2019-318296. doi: 10.1136/gutjnl-2019-318296.
    PubMed     Text format    


    Inflamm Bowel Dis

  11. DALAL RS, Osterman MT, Buchner AM, Praestgaard A, et al
    A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310380. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. ADEDOKUN OJ, Gunn GR 3rd, Leu JH, Gargano C, et al
    Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310409. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. NEXOE AB, Pilecki B, Von Huth S, Husby S, et al
    Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310373. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. BHAT S, Zahorian T, Robert R, Farraye FA, et al
    Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310379. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. NISSEN LHC, Derikx LAAP, Jacobs AME, van Herpen CM, et al
    Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018;24:2015-2026.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  16. PLEVRIS N, Chuah CS, Allen RM, Arnott ID, et al
    Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.
    J Crohns Colitis. 2019 Feb 14. pii: 5320521. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. BRINK GVD, Gaalen MACV, de Ridder L, van der Woude CJ, et al
    Health Care Transition Outcomes in Inflammatory Bowel Disease: a Multinational Delphi Study.
    J Crohns Colitis. 2019 Feb 14. pii: 5320372. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. DAI C, Jiang M, Yu JH
    Long-term outcomes of Proactive therapeutic drug monitoring of adalimumab and standard of care in patients with inflammatory bowel disease.
    J Crohns Colitis. 2019 Feb 7. pii: 5308914. doi: 10.1093.
    PubMed     Text format    


    J Immunol

  19. LEBER A, Hontecillas R, Zoccoli-Rodriguez V, Chauhan J, et al
    Oral Treatment with BT-11 Ameliorates Inflammatory Bowel Disease by Enhancing Regulatory T Cell Responses in the Gut.
    J Immunol. 2019 Feb 13. pii: jimmunol.1801446. doi: 10.4049/jimmunol.1801446.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  20. KING JA, Underwood FE, Panaccione N, Quan J, et al
    Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
    Lancet Gastroenterol Hepatol. 2019 Feb 11. pii: S2468-1253(19)30013.
    PubMed     Text format     Abstract available


    PLoS One

  21. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: